American International Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,532
| Closed | -$463K | – | 3394 |
|
|
2022
Q1 | $463K | Sell |
16,532
-1,164
| -7% | -$31.9K | ﹤0.01% | 1764 |
|
|
2021
Q4 | $483K | Sell |
17,696
-529
| -3% | -$14.3K | ﹤0.01% | 1832 |
|
|
2021
Q3 | $496K | Sell |
18,225
-433
| -2% | -$10.7K | ﹤0.01% | 1864 |
|
|
2021
Q2 | $319 | Sell |
18,658
-298
| -2% | -$5.58K | ﹤0.01% | 2217 |
|
|
2021
Q1 | $396 | Buy |
18,956
+51
| +0.3% | +$1.18K | ﹤0.01% | 1957 |
|
|
2020
Q4 | $433 | Sell |
18,905
-542
| -3% | -$10.3K | ﹤0.01% | 1836 |
|
|
2020
Q3 | $317K | Sell |
19,447
-443
| -2% | -$8.02K | ﹤0.01% | 1845 |
|
|
2020
Q2 | $269K | Buy |
19,890
+1,708
| +9% | +$19.9K | ﹤0.01% | 1958 |
|
|
2020
Q1 | $215K | Sell |
18,182
-1,050
| -5% | -$23.3K | ﹤0.01% | 1868 |
|
|
2019
Q4 | $479K | Sell |
19,232
-162
| -0.8% | -$3.28K | ﹤0.01% | 1716 |
|
|
2019
Q3 | $330K | Sell |
19,394
-136
| -0.7% | -$2.48K | ﹤0.01% | 1881 |
|
|
2019
Q2 | $445K | Buy |
19,530
+439
| +2% | +$11.8K | ﹤0.01% | 1765 |
|
|
2019
Q1 | $614K | Sell |
19,091
-618
| -3% | -$19.1K | ﹤0.01% | 1588 |
|
|
2018
Q4 | $555K | Sell |
19,709
-150
| -0.8% | -$4.39K | ﹤0.01% | 1612 |
|
|
2018
Q3 | $571K | Buy |
19,859
+562
| +3% | +$16.9K | ﹤0.01% | 1808 |
|
|
2018
Q2 | $723K | Buy |
19,297
+2,299
| +14% | +$90.3K | ﹤0.01% | 1595 |
|
|
2018
Q1 | $668K | Sell |
16,998
-914
| -5% | -$33.4K | ﹤0.01% | 1512 |
|
|
2017
Q4 | $580K | Buy |
17,912
+497
| +3% | +$14.9K | ﹤0.01% | 1697 |
|
|
2017
Q3 | $542K | Buy |
17,415
+1,303
| +8% | +$38.6K | ﹤0.01% | 1717 |
|
|
2017
Q2 | $450K | Buy |
16,112
+408
| +3% | +$9.24K | ﹤0.01% | 1777 |
|
|
2017
Q1 | $269K | Buy |
15,704
+1,037
| +7% | +$14.5K | ﹤0.01% | 1989 |
|
|
2016
Q4 | $177K | Sell |
14,667
-39
| -0.3% | -$505 | ﹤0.01% | 2268 |
|
|
2016
Q3 | $233K | Buy |
14,706
+22
| +0.1% | +$331 | ﹤0.01% | 2060 |
|
|
2016
Q2 | $190K | Buy |
14,684
+6,318
| +76% | +$98.9K | ﹤0.01% | 2159 |
|
|
2016
Q1 | $159K | Buy |
8,366
+32
| +0.4% | +$580 | ﹤0.01% | 2991 |
|
|
2015
Q4 | $188K | Sell |
8,334
-15
| -0.2% | -$297 | ﹤0.01% | 2914 |
|
|
2015
Q3 | $195K | Buy |
8,349
+90
| +1% | +$2.48K | ﹤0.01% | 2863 |
|
|
2015
Q2 | $236K | Buy |
8,259
+4,572
| +124% | +$120K | ﹤0.01% | 2857 |
|
|
2015
Q1 | $95.2K | Hold |
3,687
| – | – | ﹤0.01% | 3605 |
|
|
2014
Q4 | $68.4K | Buy |
+3,687
| New | +$66.3K | ﹤0.01% | 3821 |
|
American International Group's XENT Position: Q2 2022 in Review
American International Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 16,532 shares — an estimated $463K sold.
American International Group first reported a position in XENT in Q4 2014 and held it in 30 quarters. The position peaked at $723K in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- American International Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- American International Group sold 16,532 Intersect ENT, Inc shares in Q2 2022, an estimated $463K.
- American International Group first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 30 quarters.
- American International Group's Intersect ENT, Inc position peaked at $723K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.